(Q53424963)

English

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.

scientific article published on 9 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

Laura J. Havrilesky

5

object named as

Laura J Havrilesky

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Angeles Alvarez Secord

8

object named as

Angeles Alvarez Secord

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Kathleen M Darcy

2

object named as

Kathleen M Darcy

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Andrew Berchuck

7

object named as

Andrew Berchuck

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

6

object named as

Lisa A Grace

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

4

object named as

Sarah M Bean

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

3

object named as

Alan Hutson

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

author name string

Jennifer M Rubatt

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

language of work or name

0 references

publication date

9 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

112

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

469-474

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Angiogenesis in primary and metastatic epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

The prognostic value of endoglin (CD105) expression in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Different features of angiogenesis between ovarian and breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

CD105 expression is an independent predictor of survival in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

High expression of CD105 as a prognostic predictor of early tongue cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Endoglin (CD105) expression in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.030

7 January 2021

Identifiers

10.1016/J.YGYNO.2008.11.030

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/19135712

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53424963&oldid=1739979993"